<DOC>
	<DOCNO>NCT02111265</DOCNO>
	<brief_summary>Compare efficacy safety closed-loop target control infusion propofol etomidate general anesthesia geriatric patient</brief_summary>
	<brief_title>THe Comparison Target Controlled Infusion Propofol Etomidate General Anesthesia Geriatric Patients</brief_title>
	<detailed_description />
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Sufentanil</mesh_term>
	<mesh_term>Etomidate</mesh_term>
	<mesh_term>Remifentanil</mesh_term>
	<mesh_term>Cisatracurium</mesh_term>
	<mesh_term>Atracurium</mesh_term>
	<criteria>1 . Written informed consent . 2 . Scheduled Endotracheal intubated general anesthesia general surgery patient . 3 . Age 6075 yr . 4 . American Society Anesthesia ( ASA ) classification III . 5 . Expected time surgery le 3 hour . 1 . Body mass index 36kg/m2 . 2 . Systolic blood pressure≥180 mm Hg &lt; 90 mm Hg，diastolic blood pressure≥110 mm Hg &lt; 60 mm Hg . 3 . Serious cardiac , cerebral , liver , kidney , lung , endocrine disease sepsis . 4 . Long term use hormone adrenal suppression . 5 . Allergy trial drug contraindication . 6 . Difficult airway occur , difficult airway possibly occur difficult extubation . 7 . Abuse narcotic analgesia suspect . 8 . Neuromuscular disease . 9 . Mentally unstable mental illness . 10 . Malignant Hyperthermia . 11 . Pregnant breastfeed woman . 12 . Attended trial past 30 day .</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>